Kala制藥
KALA----
全部股東
股東類型
- 公眾及其他90.92%
- 機構投資者8.78%
- 個人與內幕人士0.30%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Halevi Enterprises | 4.70% | 90.97 萬 | -- | +90.97 萬 | 14/10/2026 |
Vanguard Capital Management, LLC | 1.67% | 32.20 萬 | 1.66% | +32.02 萬 | 30/06/2026 |
Geode Capital Management, LLC | 0.75% | 14.52 萬 | 0.72% | +13.99 萬 | 30/06/2026 |
State Street Investment Management | 0.46% | 8.86 萬 | 0.45% | +8.80 萬 | 30/06/2026 |
BlackRock, Inc. | 0.37% | 7.15 萬 | 0.37% | +7.13 萬 | 30/06/2026 |
Nachum Labkowski | 0.30% | 5.73 萬 | -- | +5.73 萬 | 14/10/2026 |
LifeSci Capital, LLC | 0.23% | 4.40 萬 | <0.01% | +0 | 30/12/2025 |
Northern Trust Global Investments | 0.22% | 4.16 萬 | 0.21% | +4.14 萬 | 30/06/2026 |
Oxford Finance LLC | 0.17% | 3.24 萬 | <0.01% | +0 | 25/11/2025 |
Qube Research & Technologies Ltd | 0.06% | 1.11 萬 | -- | +1.11 萬 | 30/06/2026 |
The Goldman Sachs Group, Inc. | 0.06% | 1.09 萬 | 0.05% | +1.06 萬 | 30/06/2026 |
UBS Asset Management AG | 0.05% | 9,057.00 | 0.04% | +7,720.00 | 30/06/2026 |
SR One Capital Management, LP | 0.04% | 6,884.00 | <0.01% | +0 | 14/10/2025 |
Baker Bros. Advisors LP | 0.01% | 2,312.00 | <0.01% | +0 | 31/03/2026 |
Spearhead Insurance Solutions Idf, Llc | <0.01% | 775.00 | <0.01% | +0 | 14/02/2025 |
Tower Research Capital Europe Limited | <0.01% | 616.00 | <0.01% | +616.00 | 30/06/2026 |
Barclays Bank Plc | <0.01% | 608.00 | -- | +608.00 | 30/06/2026 |
Andrew KovenFormer Lead Independent Director | <0.01% | 270.00 | <0.01% | +0 | 29/12/2025 |
Darius KharabiFormer Chief Business Officer | <0.01% | 258.00 | <0.01% | +0 | 22/10/2025 |
Charles MyersFormer Independent Director | <0.01% | 178.00 | <0.01% | +0 | 29/12/2025 |